Hereditary Hemorrhagic Telangiectasia
📧 Sign up to get email alerts when something new happens for Hereditary Hemorrhagic Telangiectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. [Phase 2]
Phase 2 trial evaluating oral nintedanib for epistaxis in hereditary hemorrhagic telangiectasia has completed.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Comprehensive HHT Outcomes Registry of the United States (CHORUS)
CHORUS is a comprehensive United States outcomes registry for hereditary hemorrhagic telangiectasia (HHT) and related vascular malformations…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Institutional Registry of Haemorrhagic Hereditary Telangiectasia
An update on a recruiting registry for hereditary hemorrhagic telangiectasia, sponsored by Hospital Italiano de Buenos Aires.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose [Phase 1, Phase 2]
Phase 1/2 trial evaluating intranasal bevacizumab for nasal telangiectasia in hereditary hemorrhagic telangiectasia to identify an effective…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia [NA]
A prospective study evaluating antiplatelet and anticoagulation therapy for hereditary hemorrhagic telangiectasia is currently recruiting, s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Doxycycline for Hereditary Hemorrhagic Telangiectasia [Phase 2]
This clinical trial update indicates that the Phase 2 study of doxycycline for hereditary hemorrhagic telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 study evaluating tacrolimus for hereditary hemorrhagic telangiectasia-related epistaxis has completed.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Quality of Life in Patients With Hemorrhagic Telangiectasia
This clinical trial update describes a study assessing quality of life in patients with hereditary hemorrhagic telangiectasia. The trial is …
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Clinical trial update from Odense University Hospital describes an active-not-recruiting study in Denmark examining hereditary hemorrhagic t…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia
Completed clinical trial investigating genotype-phenotype associations in hereditary hemorrhagic telangiectasia. The study update may inform…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Sirolimus for Nosebleeds in HHT [Phase 2]
Sirolimus was studied in a Phase 2 trial for nosebleeds associated with hereditary hemorrhagic telangiectasia, and the study has completed e…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Tourniquet-Test in HHT [NA]
Clinical trial update indicates a tourniquet-test study for hereditary hemorrhagic telangiectasia is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHT
A clinical trial evaluates video-assisted instructions for nasal self-packing in patients with hereditary hemorrhagic telangiectasia. The st…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
A clinical trial update studying how hypoxia-related factors affect patients with hereditary hemorrhagic telangiectasia; the study is curren…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Hereditary Haemorrhagic Telangiectasia Flight Safety Study
A completed clinical trial evaluating flight safety in individuals with hereditary hemorrhagic telangiectasia has posted its results. The st…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Pomalidomide for the Treatment of Bleeding in HHT [Phase 2]
Phase 2 trial of pomalidomide for reducing bleeding in hereditary hemorrhagic telangiectasia has completed and results were posted in 2024.
-
CLINICAL_TRIALS research · 2024-03-29Clinical Trial Update: Diet and Hereditary Haemorrhagic Telangiectasia [NA]
A completed clinical trial evaluating the impact of diet on Hereditary Hemorrhagic Telangiectasia (HHT) with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept [Phase 1, Phase 2]
Phase 1/2 trial evaluating a topical anti-angiogenic therapy for hereditary hemorrhagic telangiectasia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia [Phase 1, Phase 2]
A clinical trial evaluating pazopanib for epistaxis in hereditary hemorrhagic telangiectasia (HHT) at Phase 1/2 stages. Current status is un…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients [Phase 3]
Phase 3 trial completed evaluating propranolol for reducing epistaxis in hereditary hemorrhagic telangiectasia.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia [Phase 2]
Phase 2 trial update for timolol gel addressing epistaxis in hereditary hemorrhagic telangiectasia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Intranasal Bevacizumab for HHT-Related Epistaxis [Phase 4]
Phase 4 trial update on intranasal bevacizumab for hereditary hemorrhagic telangiectasia (HHT) with epistaxis has completed; results posted …
-
CLINICAL_TRIALS research · 2020-05-28Clinical Trial Update: Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) [NA]
A completed prospective pilot study evaluating the use of Floseal for anterior epistaxis in patients with hereditary hemorrhagic telangiecta…
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 trial evaluating submucosal bevacizumab for recurrent epistaxis in hereditary hemorrhagic telangiectasia (HHT) has completed, with r…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 trial investigating topical bevacizumab for managing recurrent epistaxis in patients with hereditary hemorrhagic telangiectasia is c…